This content is machine translated Parkinson's disease What to do in case of respiratory disorders? Pneumologic and neurologic dysfunction occur equally in PD and are typical of the disease. It is therefore important to be mutually considerate: Pneumologists must not disregard the fact that respiratory…
View Post 7 min This content is machine translated Non-infectious complications after HSCT Cure for multiple sclerosis at any price? Hematopoietic stem cell transplantation (HSCT) is used as ultima ratio in multiple sclerosis. The reboot of the immune system is aimed at healing, but carries strong side effects. Both infectious…
View Post 5 min This content is machine translated Moderate asthma What drives the physician’s therapy decision When treating asthma patients, many thoughts run through the physician’s mind – after all, on the one hand he usually has several therapy options, but on the other hand he…
View Post 2 min This content is machine translated GINA Guideline 2020 New weapon at level 5 The Global Initiative for Asthma (GINA) has also updated its recommendations for asthma management in 2020. The most important announcement in it for the occasion: during the COVID-19 pandemic, patients…
View Post 11 min This content is machine translated Thoracic surgery operations Prevention and treatment of respiratory and cardiac disorders. Any surgery can cause problems with the circulation, heart or lungs postoperatively. The prevention of such complications and their treatment is of great importance, because otherwise the perioperative risk increases… CME-Test
View Post 7 min This content is machine translated Non-infectious complications after HSCT Lungs at high risk! Hematopoietic stem cell transplantation (HSCT) is an established treatment for a variety of malignant and non-malignant diseases. However, both infectious and noninfectious pulmonary complications can lead to increased morbidity and…
View Post 4 min This content is machine translated Chronic obstructive pulmonary disease (COPD) Reduce exacerbation rate and improve quality of life Assessment of symptoms and exacerbation risks is central to effective drug therapy. The ABCD risk classification serves as a basis for this. Here, the indication for therapy is based on…
View Post 6 min This content is machine translated Antisynthetase syndromes Watch your fingers The antisynthetase syndromes are a subgroup of the idiopathic inflammatory myopathies and account for approximately 35-40% of cases here. However, if detected in time, the long-term prognosis for affected individuals…
View Post 4 min This content is machine translated Update GINA Guidelines 2020 Asthma therapy in transition During several decades, short-acting beta-mimetics (SABA) were recommended as first-line therapy. This has changed in the meantime. The current GINA treatment recommendations advise instead the use of an anti-inflammatory demand…
View Post 4 min This content is machine translated COPD therapy The less eosinophilic the COPDer, the more unnecessary the ICS “Treatable traits” is the new magic term in the treatment of COPD, and the current guidelines are modeled after it. With regard to the structure of therapy, the focus should…
View Post 3 min This content is machine translated Cystic fibrosis In the sweat of the CF Next to hematomatosis, cystic fibrosis (CF) is the most common genetic disease and the most common genetic disease with lung involvement. In adult patients, the symptoms are varied and often…
